Page 1 of 5
Sort by: Relevance | Date
This article is part of a Supplement: Volume 6 Supplement 1
The Correction to this article has been published in Journal for ImmunoTherapy of Cancer 2019 7:46
This article is part of a Supplement: Volume 18 Supplement 1
The Correction to this article has been published in Trials 2018 19:99
This article is part of a Supplement: Volume 11 Supplement 1
This article is part of a Supplement: Volume 11 Supplement 1
This article is part of a Supplement: Volume 6 Supplement 1
The Correction to this article has been published in Journal for ImmunoTherapy of Cancer 2019 7:46
This article is part of a Supplement: Volume 20 Supplement 1
This article is part of a Supplement: Volume 13 Supplement 4
This article is part of a Supplement: Volume 7 Supplement 1
This article is part of a Supplement: Volume 4 Supplement 1
This article is part of a Supplement: Volume 1 Supplement 3
This article is part of a Supplement: Volume 18 Supplement 3
This article is part of a Supplement: Volume 16 Supplement 1
This article is part of a Supplement: Volume 5 Supplement 2
A proteomic approach using a cleavable ICAT reagent and nano-LC ESI tandem mass spectrometry was used to perform protein profiling of core RBC membrane skeleton proteins between sickle cell patients (SS) and c...
The ethics and scientific integrity of biomedical and public health research requires that researchers behave in appropriate ways. However, this requires more than following of published research guidelines th...
This article is part of a Supplement: Volume 21 Supplement 1
A1 Pirfenidone inhibits TGF-b1-induced extracellular matrix production in nasal polyp-derived fibroblasts
This article is part of a Supplement: Volume 9 Supplement 1
The editors of BMC Biotechnology would like to thank all our reviewers who have contributed to the journal in Volume 15 (2015).
This article is part of a Supplement: Volume 18 Supplement 1
The Correction to this article has been published in Orphanet Journal of Rare Diseases 2023 18:370
Pseudomonas syringae pv. phaseolicola, the causal agent of halo blight disease in beans, produces a toxin known as phaseolotoxin, in whose synthesis participate a group of genes organized within the genome in a r...